Health‐related quality of life among adults with haemophilia in China: A comparison with age‐matched general population
- 25 June 2022
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 28 (5) , 776-783
Abstract
Introduction: Evaluating health‐related quality of life (HRQoL) is vital for informing the improvement of the overall health of people with haemophilia (PwH). While there is lacking such data in China and comparisons with the general population.Aim: To evaluate the HRQoL and its associated factors among adults with haemophilia, and compare it with a sample of the general population in China.Methods: PwH were recruited in this study using telephone‐based interviews. Demographic and clinical characteristics were first collected. HRQoL was then evaluated using the self‐reported Short Form 6‐dimensions version 2 (SF‐6Dv2) instrument. An age and gender‐matched sample of the general population in China was also included as the comparator group. Linear regression was used to assess the association between the SF‐6Dv2 utility value and the demographic and clinical variables of the patients.Results: This study included 206 PwH (mean [SD] age: 41.36 [14.48] years) and 206 respondents from the general population. PwH reported worse levels in physical functioning, role limitation, social functioning, and mental health dimensions on SF‐6Dv2 than the general respondents. The mean (SD) utility of patients was .650 (.251), which was significantly lower than the general respondents (.786 [.183],P < .001). Being a student, having a higher monthly income, absence of comorbidities, having no target joints and requiring no treatment are independent predictors of a higher HRQoL for PwH.Conclusion: This study provides the first practical evidence of a significantly lower level of HRQoL in PwH than in the general population in China.Keywords
This publication has 36 references indexed in Scilit:
- The demographics, treatment characteristics and quality of life of adult people with haemophilia in China – results from the HERO studyHaemophilia, 2016
- Social/economic costs and quality of life in patients with haemophilia in EuropeThe European Journal of Health Economics, 2016
- Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?PharmacoEconomics, 2016
- The impact of social factors on outcomes in patients with bleeding disordersHaemophilia, 2015
- Quality of life in adult patients with haemophilia – a single centre experience from SwedenHaemophilia, 2012
- Co‐morbidities and quality of life in elderly persons with haemophiliaBritish Journal of Haematology, 2010
- Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA PerspectiveValue in Health, 2007
- Assessing health‐related quality‐of‐life in individuals with haemophilia in ChinaHaemophilia, 2004
- Haemophilias A and BThe Lancet, 2003
- Deriving a Preference-Based Single Index from the UK SF-36 Health SurveyJournal of Clinical Epidemiology, 1998